Diagnosis of complex neurological and neurodegenerative conditions typically takes at least three to five years, and can involve multiple, costly and invasive medical procedures.

The complex neurological and neurodegenerative conditions under investigation include: ataxia, early-onset dementia, hereditary spastic paraplegia, early-onset Parkinson’s disease, dystonia, early-onset motor neurone disease, and undiagnosed multisystem disease.

Early diagnosis by genomic sequencing may circumvent expensive, ongoing and invasive medical investigations: avoiding distress associated with the “diagnostic odyssey” often experienced before a definitive diagnosis is reached, reducing patient and family burden, and ensuring that early, better targeted support services (such as mental health and disability services) can be provided.

Click here for information on Melbourne Genomics'  complex neurological and neurodegenerative diseases project.

Subscribe

We could talk genomics all day, but we’ll send you only what’s useful and interesting.

Melbourne Genomics acknowledges the Wurundjeri people of the Kulin Nation, on whose lands we work, and all First Nations peoples across Victoria. We pay respect to Elders past and present. We also acknowledge the First Nations health professionals, researchers and leaders who are shaping the future of genomic medicine.

© 2014–2022 Melbourne Genomics Health Alliance